Oramed | Market Exclusive

Home Tags Oramed

Inside The FDA: Eli Lilly and Co (NYSE:LLY) Jardiance Aims at...

David Rich - September 9, 2016 0

The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NYSE:NVO)...

- August 8, 2016 1

Oramed Gets Buy Rating From FBR & Co. Target: $20

- July 29, 2016 0

The Top Four Diabetes Best Sellers and One Oral Insulin Pill...

David Rich - June 22, 2016 0

Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)

David Rich - May 23, 2016 0

Oramed Pharmaceuticals, Inc.(NASDAQ:ORMP) To Release Phase IIB Clinical Data On Lead...

David Rich - May 17, 2016 0

These Five Biotechs Are Undervalued

Roger Hannington - August 31, 2015 0

Oramed is about to Revolutionize Diabetes Treatment

Roger Hannington - August 13, 2015 0

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 22, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Oramed